The mechanisms by which growth factors cooperate with cell adhesion molecules to modulate epithelial cell motility remain poorly understood. Here, we investigated the role of the E-cadherin/catenin complex in insulin-like growth factor (IGF-I)-dependent cell migration and invasion. We used variants of the HCT-8 colon cancer family that differ in their expression of aE-catenin, an intracellular molecule that links the E-cadherin/catenin complex to the actin cytoskeleton. Migration was determined using a monolayer wound model and cell invasion by the penetration of the cells into type-I collagen gels. We showed that acatenin-deficient cells were not able to migrate in cohort upon IGF-I stimulation. Transfection of these cells with acatenin isoforms (aN-or aT-catenin) restored migratory response IGF-I. These results suggest that a-catenins are involved in the signal issued from the E-cadherin/catenin complex to regulate IGF-I-stimulated migration. In contrast, IGF-I promoted invasion of both a-catenindeficient and a-catenin-expressing cells, indicating that acatenin did not participate in the regulation of IGF-Iinduced invasion. Inhibition of E-cadherin function by treatment with MB-2 monoclonal antibodies inhibited both IGF-I-dependent cell migration and invasion. Taken together, our results indicate that functional a-catenin is essential for migration but not for invasion, while E-cadherin is involved in both phenomena.
Introduction
To colonize new organ sites, cancer cells must access the lymphatic and blood vessels, disseminate, extravasate and invade the new organ's parenchyma. All these processes require events involving cell adhesion, migration, local and distant invasion. Although the detailed mechanisms of cell motility are not yet understood, it is now clear that dynamic and reciprocal interactions between cell adhesion molecules, extracellular matrix and soluble factors are essential (Conacci-Sorrell et al., 2002; Schwartz and Ginsberg, 2002) .
Insulin-like growth factors (IGF-I and IGF-II) are multifunctional regulatory peptides that share structural homology with proinsulin and mediate several signaling pathways involved in cell proliferation, differentiation and survival. There is increasing evidence that IGFs are also able to stimulate cell motility (Leventhal and Feldman, 1997) . IGFs exert these effects through the IGF-I receptor (IGF-IR), a tyrosine kinase heterotetramer homologous to the insulin receptor (Furstenberger and Senn, 2002 ). An early step in signal transduction by IGF-IR is the extensive tyrosine phosphorylation of IRS-1, which initiates several distinct signaling pathways such as phosphatidyl inositol-3 kinase (PI-3K) and mitogen-activated protein kinase cascades (Baserga, 2000) . In addition, the action of IGF-I is regulated by interactions with IGF-binding proteins (IGFBPs) that modulate the IGF bioavailability to the cell surface IGF-IR (Furstenberger and Senn, 2002) . Converging data from recent clinical and laboratory studies clearly indicate that the IGF system is involved in the pathogenesis of colorectal cancers (Furstenberger and Senn, 2002; Sandhu et al., 2002) .
In epithelial cells, intercellular adhesion is primarily mediated by E-cadherin, a 120-kDa calcium-dependent transmembrane glycoprotein. Extracellularly, E-cadherin molecules associate in a homophilic way to promote specific cell-cell adhesion (Angst et al., 2001) . The cytoplasmic domain of E-cadherin binds noncovalently to b-catenin or g-catenin (Angst et al., 2001) . Both band g-catenins bind a-catenin that can link directly or indirectly the actin cytoskeleton. To date, three acatenin subtypes have been described: aE-catenin, aNcatenin and aT-catenin (Janssens et al., 2001) . The dysfunction and the loss of the E-cadherin/catenin complex have been strongly implicated in carcinogenesis and invasiveness of epithelial tumor cells (Mareel and Leroy, 2002) . The E-cadherin/catenin complex can be regulated at multiple levels, for example, mutations in cadherin or catenin genes vs functional inactivation of the complex by tyrosine phosphorylation. A number of soluble factors, including hepatocyte growth factor, epidermal growth factor and IGF-I have been involved in the regulation of the E-cadherin/catenin complex (Bracke et al., 1993; Andre´et al., 1999b; Hiscox and Jiang, 1999) , suggesting that cell-cell junction proteins can be common targets for motogenic factors.
In order to elucidate the role of the interplay between IGF-IR and E-cadherin/catenin complex in cancer pathogenesis, the impact of IGF-I on epithelial cell migration and invasion was analysed. To this end, we mainly used derivatives isolated from the human colon cancer cell line HCT-8, which differ in their expression levels of a-catenin and their ability to invade into different extracellular matrices in vitro (Vermeulen et al., 1995) . Our results indicate that, in the presence of IGF-I, a-catenin expression is required for cellular migration but is dispensable for tumor cell invasion, while Ecadherin is involved in both processes.
Results

Both HCT-8/E11 and HCT-8/E11R1 cells express a fully active IGF-IR
We first analysed whether both HCT-8/E11 and acatenin-deficient HCT-8/E11R1 cells expressed the IGF-IR. For this purpose, immunoprecipitation of cell surface biotin-labeled proteins was carried out with a-IR3, an anti-IGF-IR monoclonal antibody (mAb) (Figure 1a ). We co-precipitated both the a-(130 kDa) and b-(100 kDa) subunits of the IGF-IR from both HCT-8 cell variants. No major difference in IGF-IR expression level was detectable between HCT-8/E11 and HCT-8/E11R1 cell lines. To investigate whether IGF-I induced tyrosine autophosphorylation of the IGF-IR bsubunit, HCT-8 cell variants were stimulated or not with IGF-I. IGF-IR was then immunopurified with a-IR3 mAb and analysed by Western blotting with PY20, an antiphosphotyrosine antibody (Figure 1b) . The b-subunits of the IGF-IR were phosphorylated upon IGF-I stimulation. Tyrosine phosphorylation of intracellular substrates of IGF-IR was further examined by Western blotting using PY20 mAb (Figure 1c ). The level of tyrosine phosphorylation of a 185 kDa protein (presumably a protein belonging to insulin receptor substrate protein family) and a 100 kDa polypeptide (presumably the b-subunit of the IGF-IR) were significantly increased over the basal level in both HCT-8 variants with IGF-I treatment. Taken together, these data indicate that: (i) IGF-IR is expressed as a fully active form in both HCT-8/E11 and HCT-8/E11R1 cell lines and (ii) both cell variants are able to trigger a cascade of reactions involved in the IGF-IR signal transduction pathway, independent of a-catenin expression.
a-Catenin is involved in the IGF-I-dependent cohort migration
We first determined whether IGF-I was involved in motility of isolated cells. Isolated cells plated on plastic Immunopurified receptors were subjected to SDS-PAGE, transferred onto a nitrocellulose sheet and revealed with HRPstreptavidin and ECL system. (b) HCT-8/E11 and HCT-8/E11R1 cells were stimulated or not for 1 min with 14 nM des(1-3)-IGF-I, then lysed. IGF-IR were immunoprecipitated as in (a), and revealed by Western blotting with PY20 mAb. (c) HCT-8/E11 and HCT-8/E11R1 cells were stimulated or not for 1 min with 14 nM des(1-3)-IGF-I. Cell lysates were subjected to SDS-PAGE and blotted onto nitrocellulose. Tyrosine phosphorylated proteins were detected using PY20 mAb and revealed with ECL system a-catenin in cancer cells invasion and migrationwere treated for 5 h with or without des(1-3)IGF-I, a truncated analogue that binds with high affinity to the IGF-IR but not IGFBPs. The positions of the cell nuclei were analysed every 5 min. Using this assay, we determined that both HCT-8 cell variants exhibited same velocity rates (23.6 vs 24.1 mM/h for HCT-8/E11R1 and HCT-8/E11 respectively). Moreover, IGF-I did not affect the motility of any of the two HCT-8/E11 cell variants (25.8 vs 24.3 mM/h for HCT-8/E11R1 and HCT-8/E11, respectively), indicating that a-catenin is not necessary for random motility.
We next examined the function of a-catenin in cohort migration using a woundhealing assay (Figure 2a ). Both HCT-8/E11 and HCT-8/E11R1 cells migrated spontaneously, without exogeneous stimulus. IGF-I did not increase the number of HCT-8/E11R1 migrating cells, whereas it stimulated HCT-8/E11 cell migration in a dose-dependent manner. This effect could be observed for a concentration as low as 1 nM and reached a plateau for a concentration of 14 nM.
To check whether IGFBPs could modulate IGF bioavailability, we used des(1-3)-IGF-I. As shown in Figure 2a , des(1-3)-IGF-I had no effect on the HCT-8/ E11R1 cell migration whatever the concentration tested, whereas it increased the number of HCT-8E/11 migrating cells. This des(1-3)-stimulated migration was always higher than that observed using IGF-I, suggesting that IGFBPs partially inhibited IGF-I-stimulated cell migration. For subsequent experiments, des(1-3)-IGF-I was therefore used at the concentration of 14 nM, that is, the concentration inducing the maximal stimulation of HCT-8/E11 cells.
To delineate whether IGF-I-dependent cell migration was directly mediated through IGF-IR, we preincubated wounded monolayers with 10 mg/ml a-IR3 (Figure 2b ). a-IR3 dramatically reduced the HCT-8/E11 migratory response to IGF-I, indicating that the effect of IGF-I on cell migration was mediated through IGF-IR. The specificity was tested with an irrelevant mouse antibody (data not shown).
The wounded monolayers also exhibited differences of morphology, as shown in Figure 3 . The leading edge of HCT-8/E11 monolayer had a relatively smooth shape reflecting a directional migration, whereas jagged wound Time-lapse microscopy was used to detail some events involved in IGF-I-stimulated migration. As observed in Figure 4a , nuclei tracks of HCT-8/E11 cells were roughly parallel, indicating that cells migrate unidirectionally towards the center of the wound without loosing contact with their neighbors. Des(1-3)-IGF-I enhanced the migration velocity rate from 8 to 12-15 mM/h (Figure 4b ). In contrast, nuclei tracks of HCT-8E11R1 cells were not parallel, indicating that cells moved in various directions without close cell-cell contacts (Figures 4c and 4d ). Using this assay, we were not able to detect any effect of des(1-3)-IGF-I on HCT-8/E11R1 movement, since migration velocity rates were 5 and 4.5 mM/h for control and des(1-3)-IGF-I-treated cells, respectively.
Taken together, these results suggest that a-catenin is involved in IGF-I-induced directional migration. To confirm this hypothesis, a-catenin-deficient HCT-8/ E11R1 cells were transfected with aT-or aN-catenin expression vectors, then wounded and treated or not with des(1-3)-IGF-I ( Figure 5 ). Both parental and HCT-8/R1/1743 control cells were insensitive to des(1-3)-IGF-I. In line with our observations on HCT-8/E11 cells, re-expression of aT-or aN-catenin in a-catenindeficient cells restored the migratory response to des(1-3)-IGF-I. These results clearly suggest that a-catenin expression is necessary for IGF-I-induced cohort migration.
IGF-I-induced invasion is independent of a-catenin expression
We examined the possibility that a-catenin may participate in the regulation of invasion ( Figure 6 ). Both isolated HCT-8 variants did not exhibit spontaneous invasiveness into type-I collagen gels. However, treatment of cells with des(1-3)-IGF-I strongly promoted invasion of the two HCT-8 variants. Invasion was dramatically inhibited by a-IR3 mAb. We verified that irrelevant mouse IgG1 did not affect the IGF-I-induced invasion. As a negative control, we showed that des(1-3)-IGF-I did not induce invasion of LoVo-C5 cells, a colon cell line that does not express an active IGF-IR. These data clearly indicate that (i) IGF-I induced invasion of both HCT-8 variants into type-I collagen through the activation of the IGF-IR, and (ii) a-catenin 
Signaling pathways involved in IGF-I-induced invasion and migration
We determined the possible contribution of PI-3K, Rholike GTPases and heterotrimeric G-proteins in the migratory and proinvasive activity of IGF-I in HCT-8/ E11 and HCT-8/E11R1 colonic cells. Wortmannin (10 nM) and LY29004 (10 mM), C3 exotransferase (5 mg/ml) and pertussis toxin (200 ng/ml) almost completely inhibited cellular invasion induced by des(1-3)-IGF-I in both HCT-8 variants (Table 1) . Those inhibitors also dramatically reduced the IGF-I-stimulated HCT-8/E11 directional migration as assessed by the monolayer-wounding assay. To confirm these observations, we analysed whether dominant-negative mutants of PI-3K and rhoGTPases inhibited IGF-Idependent cell migration. As observed in Table 2 , the expression of dominant-negative forms of N19 RhoA or N17 Rac in kidney MDCK T23 cells completely abrogated the IGF-I-dependent cell migration. Introduction of the dominant-negative mutant of the PI-3 0 K p110 in kidney MDCK ts.src Cl2 cells also strongly inhibited IGF-I-dependent cell migration.
IGF-I-induced cohort migration and invasion require E-cadherin
We evaluated whether E-cadherin was involved in both invasion and migration by using three function-blocking anti-E-cadherin mAbs. Both MB2 and HECD-1 react with human E-cadherin, whereas DECMA-1 is specific for canine E-cadherin. As observed in Figure 7a , the sole addition of anti-E-cadherin mAbs MB2 or HECD-1 did not decrease the number of migrating HCT-8 cell variants. However, both MB2 and HECD-1 mAbs markedly inhibited des(1-3)-IGF-I-stimulated HCT-8/ E11 cell migration. To consolidate this observation, we tested the effect of DECMA-1 on the migration of MDCK T23 cell line (Figure 7b ). This mAb inhibited the des(1-3)-IGF-I-stimulated MDCK T23 cell migration, while MB2 mAb had no effect (not shown), confirming the specificity of the inhibition in presence of DECMA-1.
We also analysed the contribution of E-cadherin on invasion in type-I collagen (Figure 8a ). Treatment of both HCT-8/E11 and HCT-8/E11R1 cells with MB2 mAb dramatically inhibited the des(1-3)-stimulated invasion. The impact of the mAb was also tested on HCT-8 cell spreading on type-I collagen, an initial step (4) 101 (5) 95 ( For migration: monolayers were wounded and incubated for 90 min in the presence or absence of inhibitors. Monolayers were then cultured for an additional 24 h period in the presence or absence of inhibitors or 14 nM des(1-3)-IGF-I. Migrating cells were counted as described in the Materials and methods section.
[2] For invasion: cells were seeded on top of the collagen in the presence or absence of 14 nM des(1-3)-IGF-I or inhibitors and allowed to invade for 24 h. Invading cells were scored as described in Materials and methods section.
[3] Data represent mean of three separate experiments. Numbers in parentheses represent s.d. Cell monolayers were wounded, then incubated for 3.5 h in serum-free medium without or with 14 nM des(1-3)-IGF-I. The width of the wound was measured at time zero and after the incubation period. Migration was expressed as the difference between the two measurements. Results represent distance of migration (in mM) from three independent assays. Numbers in parentheses represent s.d.
a-catenin in cancer cells invasion and migration F André et al of invasion (Figure 8b ). MB2 mAb abrogated des(1-3)-IGF-I-induced spreading of both HCT-8/E11R1 and HCT-8/E11 cells. Taken together, these data suggest that E-cadherin is involved in both directional migration and invasion.
Discussion
We have analysed the interplay between IGF-IR and the E-cadherin/catenin complex during cohort migration and invasion of colonic cells. To this end, we have used a couple of variants of the HCT-8 cell line: HCT-8/E11 cells have a functional E-cadherin/catenin complex, while HCT-8/E11R1 cells are deficient in a-catenin protein (Vermeulen et al., 1995) . According to our data, the role of a-catenin and E-cadherin in IGF-I-stimulated cohort migration and invasion can be summarized as follows: (i) isolated cells on tissue culture plastic are not sensitive to IGF-I stimulation; (ii) when cell-cell contacts are established, directional migration is stimulated by IGF-I and this effect is E-cadherin and acatenin dependent; and (iii) isolated cells seeded on type-I collagen are induced by IGF-I to spread and invade, this effect being E-cadherin dependent but not requiring a-catenin. In vivo and in vitro studies indicated that carcinoma cells frequently invade the surrounding tissue as coherent clusters or nests of cells, a process termed cohort migration (Nabeshima et al., 1999) . This migration requires the coordination of several mechanisms including directional guidance and modulation of cellcell adhesion within the migrating cell groups. Both activities can be studied using the monolayer-wounding assay. We have previously shown that IGF-I is able to According to this, introduction of aT-or aN-cateninin a-catenin-deficient cells restored the migratory response to IGF-I. This finding is in agreement with recent reports, suggesting that a-catenin is required for distinct biological activities including reduction of cell death and alteration of keratinocyte proliferation and cell polarity (Matsubara and Osawa, 2001; Vasioukhin et al., 2001) . The mechanism(s) by which a-catenin expression modulates IGF-I-induced cohort migration needs to be explored in more depth. Firstly, one may speculate that a-catenin is directly involved in the IGF-I signaling pathway. Consistent with this hypothesis, studies have suggested a physical interaction between IGF-IR and Ecadherin/catenin complex (Mauro et al., 2001; Morali et al., 2001) . Moreover, loss of a-catenin alters the response of keratinocytes to several growth factors (Vasioukhin et al., 2001) . Therefore, the defect in acatenin expression or molecular structure, leading to an uncoupling between the IGF-I signaling pathway and the E-cadherin/catenin complex, may abolish the capacity of HCT-8/E11R1 cells to migrate upon IGF-I stimulation. In agreement with this, inactivation of cell-cell adhesion with anti-E-cadherin mAbs alters the IGF-I-induced tyrosine phosphorylation of some proteins (not shown). Secondly, cohort migration could be impaired by alteration between cell-cell contacts and the actin cytoskeleton. Since a-catenin is a key molecule that links the E-cadherin/b-catenin complex to the actin cytoskeleton (Angst et al., 2001 ), lack of a-catenin could cause alteration of the actin cytoskeleton and therefore coordinated migration. Since IGF-IR activation affects the actin cytoskeletal organization (Guvakova and Surmacz, 1999) , further studies are needed to explore the relationship between the IGF-IR and the actin cytoskeleton during cohort migration.
Invasion of cancer cells from various tissue origins is often inversely related to the expression of E-cadherin (Van Hoorde et al., 2000) . According to this, neither LoVo cells nor HCT-8 cells invade type-I collagen without the addition of external stimuli other than the collagen itself. In addition, since neither HCT-8/E11 nor HCT-8/E11R1 showed autonomous invasion into type-I collagen, we postulated that loss of a-catenin is neither sufficient nor necessary to stimulate invasion of epithelial colonic cells into substrata.
In our studies, IGF-I promoted cellular invasion in both HCT-8/E11 and HCT-8/E11R1 cell variants. Thus, we can conclude that a-catenin is not required for IGF-I-induced invasion. Our finding that cells, when dropped on type-I collagen gels react to IGF-I even in the absence of a-catenin, is in line with the concept that type-I collagen functions not only as a substratum but also as a proinvasive signaling substratum (Van Hoorde et al., 2000) . Along with this notion, pancreatic cancer cells dramatically reduce E-cadherin gene expression when cultured on type-I collagen, leading to increased proliferation and migration behavior (Menke et al., 2001) . Moreover, when exposed to extracellular matrix during invasion, carcinoma cells do not possess the adhesion apparatus characteristic for normal cells, and can invade despite a low level of a-catenin (Glukhova et al., 1995) . It is clear that IGF-I is not the unique cofactor necessary to stimulate invasion, since various extrinsic factors have similar effects on some epithelial cancer cells from various origins (Van Hoorde et al., 2000; Steelant et al., 2001) . However, our experiments clearly indicate that IGF-I should be considered as a potent and efficient paracrine host factor triggering invasion during colon cancer progression.
Our data clearly showed that E-cadherin plays an essential role in both IGF-I-induced cohort migration and invasion. Inhibition of cell-cell contacts using anti-E-cadherin mAb MB2 inhibited the IGF-I-induced cohort cell migration. This confirms other works suggesting that colon adenocarcinoma cells can move as coherent cell nests, while maintaining E-cadherinbased cell-cell adhesion links in some parts and extending filopodia or lamellipodia in other parts (Andre´et al., 1999b; Nabeshima et al., 1999) . We demonstrated here that inactivation of E-cadherin by MB2 mAb prevents IGF-I-induced invasion in type-I collagen, and abrogated IGF-I-induced cell spreading on type-I collagen. This discrepancy can be related to the cell types considered since the MB2 mAb prevented cellular invasion induced by IGF-I in HT29D4 cells, another colonic cancer cell line (not shown). On the other hand, it has been shown that IGF-IR belongs to the same membrane complex as E-cadherin (Morali et al., 2001) . We can thus hypothesize that MB2 mAb interfere with this membrane complex, leading to the inhibition of IGF-I-induced cellular invasion in type-I collagen. Consistent with this hypothesis, we observed that MB2 mAb alters the IGF-I-induced tyrosine phosphorylation of some proteins (not shown).
No obvious difference seems to exist between the signaling pathways used by IGF-I to convey either migratory or cellular invasion responses. Pharmacological and dominant-negative mutants of PI-3K abrogated both IGF-I-induced migration and invasion, as reported previously (Barbier et al., 2001) . Similar dependence was noticed regarding the implication of the small GTPases Rho-A and Rac-1. In line with this finding, other report indicate that the Rho-like small GTPases regulate cell motility, cell-cell adhesion and invasion (Mareel and Leroy, 2002) . Moreover, we can postulate that the IGF-R signal through heterotrimericdependent G-proteins Gao/i and Gbg since PTx inhibits IGF-induced invasion. Using MDCK cells, we demonstrated that the signaling pathways involved in IGF-Iinduced cell migration can be extended to kidney epithelial cells. Indeed, (1) pharmacological inhibitors abrogated kidney cell migration and (2) expression of dominant-negative mutants of RhoA, Rac1 or PI-3K in MDCK cells reduced the IGF-I-induced MDCK cell migration.
The microenvironment of the local host tissue can be an active participant of cellular invasion. Indeed, both in vivo and in vitro studies have demonstrated a continuous crosstalk between cancer cells, host cells (fibroblasts, myofibroblasts, endothelial and inflammatory cells) and extracellular matrix components. In this connection, previous studies demonstrated that both HCT-8/E11 and HCT-8/E11R1 cells line differed in invasiveness into different substrates and proinvasive factors. For instance, we have shown that HCT-8/E11 cells are spontaneously invasive into precultured chick heart fragments and Matrigel (Van Hoorde et al., 2000) . Furthemore, our data clearly establish that IGF-Iinduced colonic cancer cell invasion in type-I collagen is not determined by the expression of a-catenin, while the motile phenotype is a-catenin dependent. In contrast, a-catenin-deficient HCT-8/E11R1 cells are not invasive in collagen gels after the addition of bile acids and other effectors (Debruyne et al., 2002) . Therefore, IGF-I is a very pejorative proinvasive factor acting as a dominant paracrine/autocrine host factor that overcome the depletion of a-catenin in HCT-8/ E11R1 human colon cancer cells. Accordingly, we have shown that a-catenin expression in orthotopically implanted HCT-8 cells in nude mice did not influence the invasive phenotype of the tumor xenografts (Van Hoorde et al., 2000) . Further studies are needed to establish whether paracrine/autocrine IGF-I secretion in human solid tumors can be a target for future antiinvasive and -metastatic therapy.
Materials and methods
Reagents and antibodies
Dulbecco's modified Eagle's medium (DMEM), RPMI, Ham's F12, and McCoy's 5A modified medium and fetal calf serum (FCS) were purchased from Life Technologies (Ghent, Belgium). Wortmannin, LY29004, C3 exoenzyme and pertussis toxin were from Sigma (St Louis, MO, USA). Human recombinant IGF-I and des(1-3)-IGF-I were from Bachem AG (Bubendorf, Switzerland) and Gropep (Adelaide, Australia), respectively.
MB2 is a mAb against human E-cadherin with neutralizing effects on E-cadherin functions (Bracke et al., 1993) . Rat antimurine E-cadherin mAb DECMA-1 was from Sigma, whereas mouse mAb against E-cadherin was purchased from Takara (Shuzo, Kyoto, Japan). Mouse PY20 mAb antiphosphotyrosine was from Transduction Laboratories (Lexington, KY, USA). Mouse mAb against IGF-IR (a-IR3 clone) was purchased from Oncogene Science (Uniondale, NY, USA). Horseradish peroxidase sheep anti-mouse Ig was from Amersham. Mouse mAb anti-transferrin receptor (clone YDJ1.2.2) was from Immunotech (Marseille, France).
Cell lines
HCT-8/E11 and HCT-8/E11R1 are subcloned from the HCT-8 human colon carcinoma cell line (Vermeulen et al., 1995) . HCT-8/E11R1 cells are a-catenin-deficient due to a constitutive nonsense mutation in CTNNA1 and a putative second mutation causing alternative splicing (Vermeulen et al., 1999) . HCT-8 cells were cultured in RPMI containing 10% FCS. HCT-8/R1/T31 and HrpCaN1 were HCT-8/E11R1 cells transfected with a-T-and a-N-catenin, respectively (van Hengel et al., 1997; Janssens et al., 2001) . HCT-8/R1/1743 cells are HCT-8/E11R1 cells transfected with the empty PEF6MH vector and were used as a negative control. The human colonic adenocarcinoma cell lines HT29-D4 and LoVo-C5 were cultured in, respectively, DMEM and McCoy's 5A modified medium containing 10% FCS.
MDCKts.srcCl2 are Madin-Darby canine kidney cells transfected with a temperature-sensitive mutant for the src oncogene (Behrens et al., 1993) . The MDCKts.src-p110DN cell line were MDCKts.srcCl2 cells transfected with the dominant-negative mutant p110 a EcoS of PI-3K (Kotelevets et al., 1998) . The MDCKT23 cell lines expressing the mutant G-proteins Rho-A (N19 Rho) and Rac-1 (N17 Rac) were a generous gift from Dr J Nelson (Jou and Nelson, 1998).
Cohort migration
Wounding assays were essentially performed with a razor blade as described previously (Andre´et al., 1999a) , then incubated for 24 h in serum-free medium supplemented with 0.1% BSA containing test substances or not. Cell migration was assessed by counting the cell nuclei observed across the wound borders. When appropriate function-blocking mAbs were added 90 min prior to wounding and during the time of migration. Migration results are expressed as the average7s.d. of the number of migrating cells per microscopic field ( Â 200).
Owing to an higher migration velocity rate, MDCK cell monolayers were wounded with an asepticized plastic toothpick. The width of the wound was measured with an inverted microscope ( Â 200) at time zero and after a 3.5 h incubation period. For each wound, 10 measures were performed. Migration was expressed as the difference between the two measurements.
Video registration
Migration of cells after monolayer wounding was recorded by videomicroscopy. Time-lapse images were recorded with an inverted microscope (phase contrast; objective Â 32) connected with an MTI CCD72 camera (Dage MTI, Michigan City, IN, USA) and a U-matic VO-5850P videorecorder (Sony, Tokyo, Japan) at 30 s intervals. Track lengths of nuclear displacements were drawn from the display screen on transparencies for a total observation time of 6 h.
Cell motility assay
Isolated cells were allowed to attach on the substratum for 1 h in DME/10% FCS. Cells were washed three times with DME and then incubated in DME/0.1% BSA with or without 14 nM des(1-3)-IGF-I at 371C in a 5% CO 2 a-catenin in cancer cells invasion and migrationatmosphere. Image acquisition was performed every 5 min for 6 h using the Vision Explorer VA application from Graftek (Mirmande, France). ETC 300 software (Graftek) was used to analyse nuclear trajectories and to measure the nuclear velocity.
Collagen invasion assay
Collagen type-I gels (Upstate Biotechnologies; Lake Placid, NY, USA) were prepared in DMEM (0.22% w/v) using sixwell plates, as described (Vleminckx et al., 1991) . Cells were seeded on top of the collagen gels and incubated for 24 h at 371C in the presence or absence of 14 nM des(1-3)-IGF-I alone or combined with function-blocking antibodies or appropriate inhibitors of signal transduction pathways. The invasion index was calculated from the mean number of invasive cells over the total number of cells, counted in at least 12 microscopic fields.
Cell spreading assay
Overnight 24-well plates were coated at 41C with 250 ml of type-I collagen at 10 mg/ml. Coated wells were blocked with 0.5% BSA in phosphate-buffered saline (PBS) for 30 min and then washed twice with 0.1% PBS. Single-cell suspensions (25 000 cells/0.5 ml) were seeded in substratum-coated wells and allowed to adhere for 2 h at 371C. Spreading cells were counted microscopically.
Cell surface labeling and IGF-IR immunoprecipitation
Subconfluent cells were washed twice with PBS and incubated with 1 mg/ml EZ-Link Sulfo-NHS-LC-biotin (Pierce; Rockford, IL,USA) in PBS for 20 min at 41C under shaking. Cells were then washed with PBS and solubilized in RIPA buffer as described previously (Andre´et al., 1999a) . Clarified cell lysates were incubated with 10 mg/ml mAb a-IR3 overnight at 41C.
After adding Sepharose protein A (Pharmacia; North Peapack, NJ, USA) for 45 min, the suspension was centrifuged and pellets were extensively washed. Immunoprecipitated proteins were solubilized in Laemmli sample buffer, heated at 951C for 5 min, submitted to SDS-PAGE (7.5% acrylamide) under reducing conditions and blotted onto nitrocellulose sheets. Membranes were saturated with 50 mM Tris-HCl (pH 8.0), 10% glycerol, 1 M glucose, 0.5% BSA and 0.1% Tween 20 for 1 h at room temperature. Biotinylated proteins were labeled with HRP-streptavidin (Amersham; Roosendaal, The Netherlands) in the same buffer for 45 min at room temperature and were detected by the ECL system according to the manufacturer's instructions.
IGF-I-stimulated tyrosine phosphorylation
Cells were serum starved in DME containing 0.1% BSA for 2 h at 371C, then washed and stimulated with 14 nM des(1-3)-IGF-I for 1 min in the same buffer. Cells were lysed with RIPA buffer containing 5 mM sodium orthovanadate, 100 mM NaF plus the cocktail of proteases inhibitors mentioned above. IGF-IR was immunopurified from cell lysates with a-IR3 mAb as described above. Equal amounts of proteins were subjected to 7.5% acrylamide gel and transferred onto a nitrocellulose sheet. Tyrosine phosphorylated IGF-IR was probed with PY20 mAb and detected by chemiluminescence. In some experiments, tyrosine phosphorylation of cellular proteins was analysed by immunoblotting with PY 20 mAb.
